Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nuclear Medicine Communications|February 27, 2009
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agentAndrew B Newberg, Riju Ray, Joshua Scheuermann, et al.
Pharmacogenetics and Genomics|April 13, 2012
DRD1 associations with smoking abstinence across slow and normal nicotine metabolizersWonho Lee, Riju Ray, Andrew W Bergen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 10, 2011
Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokersMary Falcone, Christopher Jepson, Neal Benowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokersRiju Ray, Kosha Ruparel, Andrew Newberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 15, 2015
Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine MetabolismJacob G Dubroff, Robert K Doot, Mary Falcone, et al.
Psychopharmacology|March 6, 2012
μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect reliefMary Falcone, Allison B Gold, E Paul Wileyto, et al.
Psychiatric Genetics|November 30, 2005
A functional prodynorphin promoter polymorphism and opioid dependenceRiju Ray, Glenn A Doyle, James J Crowley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 12, 2010
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependenceRiju Ray, Nandita Mitra, Don Baldwin, et al.
Pageof 5